Clinical trials
Phase 2 Pancreatic Neoplasms trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2011 | 2 |
| 2012 | 3 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Recruiting | 7 |
| Active, not recruiting | 6 |
| Terminated | 5 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Health Network, Toronto | 5 |
| Alliance for Clinical Trials in Oncology | 3 |
| Pfizer | 3 |
| National Cancer Institute (NCI) | 2 |
| Novartis Pharmaceuticals | 2 |
| AHS Cancer Control Alberta | 1 |
| Actuate Therapeutics Inc. | 1 |
| Agensys, Inc. | 1 |
| Apollomics Inc. | 1 |
| Astellas Pharma Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 45 |
| Colorectal Neoplasms | 9 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Stomach Neoplasms | 5 |
| Breast Neoplasms | 4 |
| Lung Neoplasms | 4 |
| Neoplasms | 4 |
| Ovarian Neoplasms | 4 |
| Urinary Bladder Neoplasms | 4 |
| Biliary Tract Neoplasms | 3 |
Trials
Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.